Global Molecular Imaging Agents Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Molecular Imaging Agents Market Research Report 2024
Molecular imaging is a new biomedical research discipline which enables the quantification, visualization, and characterization of biologic processes taking place at the cellular and subcellular levels. Molecular imaging plays a very important role in diagnosis of early assessment, risk stratification, and follow-up of patients with neurological diseases. Imaging agents are the substances designed to improve the imaging output of specific organs, physiological functions, tissues and diseases. Molecular imaging agents are small molecules, peptides, engineered proteins, aptamers and nanoparticles. The main purpose of a molecular imaging agent is to cross-examine and report back about a specific target of interest during the course of a molecular imaging study.
According to Mr Accuracy reports’s new survey, global Molecular Imaging Agents market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Molecular Imaging Agents market research.
Based on types, the global molecular imaging agents market is segmented into small molecules, peptides, engineered protein fragments, aptamers, nanoparticles and others. Amongst all, peptides have emerged as a very important type of molecular imaging agents. Based on application, the global molecular imaging agents market is segmented into oncology, cardiology, gastrointestinal disorders and neurology disoeder. Similarly, based on end user, the market is segmented into, hospitals and clinics, ambulatory surgical centers, diagnostic & imaging centers, and others. Diagnostic & imaging centers are expected to hold maximum share in the market due to the ease of availability of medication.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Molecular Imaging Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
General Electric
Bracco Diagnostic
Eisai
Guerbet
Segment by Type
Small Molecules
Peptides
Engineered Protein Fragments
Aptamers
Nanoparticles
Others
Oncology
Cardiology
Gastrointestinal Disorders
Neurology Disorders
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Molecular Imaging Agents report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Molecular Imaging Agents market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Molecular Imaging Agents market research.
Based on types, the global molecular imaging agents market is segmented into small molecules, peptides, engineered protein fragments, aptamers, nanoparticles and others. Amongst all, peptides have emerged as a very important type of molecular imaging agents. Based on application, the global molecular imaging agents market is segmented into oncology, cardiology, gastrointestinal disorders and neurology disoeder. Similarly, based on end user, the market is segmented into, hospitals and clinics, ambulatory surgical centers, diagnostic & imaging centers, and others. Diagnostic & imaging centers are expected to hold maximum share in the market due to the ease of availability of medication.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Molecular Imaging Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
General Electric
Bracco Diagnostic
Eisai
Guerbet
Segment by Type
Small Molecules
Peptides
Engineered Protein Fragments
Aptamers
Nanoparticles
Others
Segment by Application
Oncology
Cardiology
Gastrointestinal Disorders
Neurology Disorders
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Molecular Imaging Agents report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source